KR0149274B1 - Medicaments for the treatment of cerebral apoplexy - Google Patents

Medicaments for the treatment of cerebral apoplexy

Info

Publication number: KR0149274B1
Authority: KR; South Korea
Prior art keywords: medicaments; treatment; cerebral apoplexy; apoplexy; cerebral
Prior art date: 1988-09-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

KR1019970061361A

Other languages

Korean (ko)

Inventor

Joerg Wilhelm Traber

Gerhard-Wilhelm Bielenbery

Original Assignee

Troponwerke Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-09-20

Filing date

1997-11-20

Publication date

1998-10-15

1988-09-20 Priority claimed from DE3831888A external-priority patent/DE3831888A1/en

1997-11-20 Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg

1998-10-15 Application granted granted Critical

1998-10-15 Publication of KR0149274B1 publication Critical patent/KR0149274B1/en

2017-11-20 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)

KR1019970061361A 1988-09-20 1997-11-20 Medicaments for the treatment of cerebral apoplexy Expired - Fee Related KR0149274B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3831888A DE3831888A1 (en)	1988-09-20	1988-09-20	MEDICINES FOR TREATING APOPLEXIA CEREBRI
KR1019890013434A KR0135307B1 (en)	1988-09-20	1989-09-19	Medications for Stroke

Publications (1)

Publication Number	Publication Date
KR0149274B1 true KR0149274B1 (en)	1998-10-15

Family

ID=25872381

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
KR1019970061359A Expired - Fee Related KR0149275B1 (en)	1988-09-20	1997-11-20	Medicaments for the treatment of cerebral apoplexy
KR1019970061361A Expired - Fee Related KR0149274B1 (en)	1988-09-20	1997-11-20	Medicaments for the treatment of cerebral apoplexy

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
KR1019970061359A Expired - Fee Related KR0149275B1 (en)	1988-09-20	1997-11-20	Medicaments for the treatment of cerebral apoplexy

Country Status (1)

Country	Link
KR (2)	KR0149275B1 (en)

1997
- 1997-11-20 KR KR1019970061359A patent/KR0149275B1/en not_active Expired - Fee Related
- 1997-11-20 KR KR1019970061361A patent/KR0149274B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR0149275B1 (en)	1998-10-15

Publication	Publication Date	Title
GB2188234B (en)	1991-01-02	Therapeutic agents
EG18268A (en)	1993-02-28	Medicament for the treatment of inflammation of the eye
CY1727A (en)	1994-05-06	Medicaments for the treatment of emesis
GB2205496B (en)	1991-12-11	Medicinal or therapeutic pack
GB8719367D0 (en)	1987-09-23	Therapeutic compounds
EP0249873A3 (en)	1990-01-10	Therapeutic agent for skin ulcers
GB8725939D0 (en)	1987-12-09	Therapeutic compounds
GB2220352B (en)	1992-03-18	Medicaments for the treatment of emesis
GB8629568D0 (en)	1987-01-21	Therapeutic agent
GB2216414B (en)	1991-12-11	Medicaments for the treatment of emesis
EP0343671A3 (en)	1990-06-13	Pharmaceutical composition for the treatment of skin wounds
GB8603447D0 (en)	1986-03-19	Therapeutic compounds
KR0149274B1 (en)	1998-10-15	Medicaments for the treatment of cerebral apoplexy
GB8720219D0 (en)	1987-10-07	Therapeutic agent
ZA877885B (en)	1988-05-04	Therapeutic agents
GB8724564D0 (en)	1987-11-25	Therapeutic compounds
EP0272929A3 (en)	1989-09-06	Enkephalinase for therapeutic use
EP0412938A3 (en)	1992-04-01	System for the treatment of contactlenses
IE883710L (en)	1989-06-14	Medicaments for the treatment of anxiety
GB8629663D0 (en)	1987-01-21	Therapeutic agents
GB8529885D0 (en)	1986-01-15	Therapeutic agent
GB8604611D0 (en)	1986-04-03	Therapeutic agent
IE863048L (en)	1987-06-04	Therapeutic agent
GR3003007T3 (en)	1993-02-17	Process for the treatment of alpha-calciumsulphate-hemihydrate
GB8703900D0 (en)	1987-03-25	Therapeutic agent

Legal Events

Date	Code	Title	Description
1997-11-20	A107	Divisional application of patent
1997-11-20	A201	Request for examination
1997-11-20	PA0107	Divisional application	St.27 status event code: A-0-1-A10-A16-div-PA0107 St.27 status event code: A-0-1-A10-A18-div-PA0107
1997-11-20	PA0201	Request for examination	St.27 status event code: A-1-2-D10-D11-exm-PA0201
1997-11-20	R17-X000	Change to representative recorded	St.27 status event code: A-3-3-R10-R17-oth-X000
1998-01-13	E902	Notification of reason for refusal
1998-01-13	PE0902	Notice of grounds for rejection	St.27 status event code: A-1-2-D10-D21-exm-PE0902
1998-03-13	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
1998-04-13	P11-X000	Amendment of application requested	St.27 status event code: A-2-2-P10-P11-nap-X000
1998-04-13	P13-X000	Application amended	St.27 status event code: A-2-2-P10-P13-nap-X000
1998-05-06	E701	Decision to grant or registration of patent right
1998-05-06	PE0701	Decision of registration	St.27 status event code: A-1-2-D10-D22-exm-PE0701
1998-06-03	GRNT	Written decision to grant
1998-06-03	PR0701	Registration of establishment	St.27 status event code: A-2-4-F10-F11-exm-PR0701
1998-06-03	PR1002	Payment of registration fee	Fee payment year number: 1 St.27 status event code: A-2-2-U10-U11-oth-PR1002
1998-10-15	PG1601	Publication of registration	St.27 status event code: A-4-4-Q10-Q13-nap-PG1601
2001-05-24	PR1001	Payment of annual fee	Fee payment year number: 4 St.27 status event code: A-4-4-U10-U11-oth-PR1001
2002-05-25	PR1001	Payment of annual fee	Fee payment year number: 5 St.27 status event code: A-4-4-U10-U11-oth-PR1001
2002-10-23	R17-X000	Change to representative recorded	St.27 status event code: A-5-5-R10-R17-oth-X000
2003-05-26	PR1001	Payment of annual fee	Fee payment year number: 6 St.27 status event code: A-4-4-U10-U11-oth-PR1001
2004-05-27	PR1001	Payment of annual fee	Fee payment year number: 7 St.27 status event code: A-4-4-U10-U11-oth-PR1001
2005-05-23	FPAY	Annual fee payment	Payment date: 20050524 Year of fee payment: 8
2005-05-24	PR1001	Payment of annual fee	Fee payment year number: 8 St.27 status event code: A-4-4-U10-U11-oth-PR1001
2006-06-04	LAPS	Lapse due to unpaid annual fee
2006-06-04	PC1903	Unpaid annual fee	Not in force date: 20060604 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE St.27 status event code: A-4-4-U10-U13-oth-PC1903
2007-05-10	PC1903	Unpaid annual fee	Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20060604 St.27 status event code: N-4-6-H10-H13-oth-PC1903
2017-07-02	P22-X000	Classification modified	St.27 status event code: A-4-4-P10-P22-nap-X000